Första AP-fonden’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.9M | Sell |
296,300
-40,600
| -12% | -$4.5M | 0.22% | 77 |
|
2025
Q1 | $37.7M | Sell |
336,900
-55,200
| -14% | -$6.19M | 0.29% | 64 |
|
2024
Q4 | $36.2M | Sell |
392,100
-5,300
| -1% | -$490K | 0.26% | 69 |
|
2024
Q3 | $33.3M | Buy |
397,400
+12,900
| +3% | +$1.08M | 0.26% | 73 |
|
2024
Q2 | $26.4M | Buy |
384,500
+19,600
| +5% | +$1.34M | 0.23% | 77 |
|
2024
Q1 | $26.7M | Buy |
364,900
+96,000
| +36% | +$7.03M | 0.23% | 84 |
|
2023
Q4 | $21.8M | Sell |
268,900
-19,600
| -7% | -$1.59M | 0.22% | 88 |
|
2023
Q3 | $21.6M | Buy |
288,500
+200
| +0.1% | +$15K | 0.24% | 76 |
|
2023
Q2 | $22.2M | Sell |
288,300
-48,400
| -14% | -$3.73M | 0.24% | 80 |
|
2023
Q1 | $27.9M | Sell |
336,700
-70,100
| -17% | -$5.82M | 0.33% | 61 |
|
2022
Q4 | $34.9M | Buy |
406,800
+101,000
| +33% | +$8.67M | 0.39% | 51 |
|
2022
Q3 | $18.9M | Sell |
305,800
-63,800
| -17% | -$3.94M | 0.23% | 98 |
|
2022
Q2 | $22.8M | Buy |
369,600
+31,500
| +9% | +$1.95M | 0.3% | 68 |
|
2022
Q1 | $20.1M | Buy |
338,100
+24,400
| +8% | +$1.45M | 0.23% | 84 |
|
2021
Q4 | $22.8M | Buy |
313,700
+21,000
| +7% | +$1.52M | 0.23% | 85 |
|
2021
Q3 | $20.4M | Buy |
292,700
+2,300
| +0.8% | +$161K | 0.23% | 85 |
|
2021
Q2 | $20M | Buy |
290,400
+18,800
| +7% | +$1.29M | 0.24% | 82 |
|
2021
Q1 | $17.6M | Buy |
271,600
+8,600
| +3% | +$556K | 0.25% | 83 |
|
2020
Q4 | $15.3M | Buy |
263,000
+48,800
| +23% | +$2.84M | 0.23% | 89 |
|
2020
Q3 | $13.5M | Buy |
214,200
+41,000
| +24% | +$2.59M | 0.28% | 73 |
|
2020
Q2 | $13.3M | Buy |
173,200
+29,600
| +21% | +$2.28M | 0.35% | 61 |
|
2020
Q1 | $10.7M | Buy |
+143,600
| New | +$10.7M | 0.39% | 57 |
|